Agency News

⚡Eli Lilly and Company, US Drugmaker, Starts Phase 3 Trial for COVID-19 Antibody Treatment

By IANS

American pharmaceutical firm Eli Lilly and Company has announced the start of its phase 3 trial to study whether one of its experimental COVID-19 antibody treatments can prevent the virus infection in residents and staff at long-term care facilities.

Read Full Story